Related Experiment Videos
Cusums to measure chronic daily headache
Edda Freidank-Mueschenborn1, Anthony W Fox
1Engelhard Arzneimittel GmbH, Niederdorfelden, Germany.
Headache
|January 18, 2006
Summary
Cumulated summed differences (cusums) can detect effective interventions for chronic daily headache (CDH) sooner than the standard 28-day observation period. This method offers a more sensitive approach for clinical trials and patient management strategies.
Area of Science:
- Neurology
- Clinical Trials Methodology
- Statistical Analysis
Background:
- Chronic daily headache (CDH) presents a significant challenge in headache treatment.
- Current clinical trial methodologies for CDH lack standardization, often relying on fixed 28-day observation periods.
- Twenty-eight-day intervals are also common for reviewing stepped-care patient management strategies.
Purpose of the Study:
- To evaluate the utility of cumulated summed differences (cusums) for detecting effective interventions in chronic daily headache (CDH).
- To determine if cusums can identify treatment efficacy earlier than the conventional 28-day observation period.
Main Methods:
- A theoretical patient model with daily headache scores exhibiting maximal variation over 28 days was developed.
- Cumulated summed differences (cusums) were calculated for a control dataset and correlated with time.
- Intervention sensitivity was assessed by observing the departure of post-intervention cusums from the 95% confidence interval of the control data.
Main Results:
- Cusums consistently diverged from the norm when the 28-day model was perturbed with 1 to 17 randomly distributed headache-free days.
- The cusum method detected interventions in less than 28 days when at least 3 headache-free days occurred.
- Reanalysis of a prior magnesium oxide study suggests its negative findings may warrant reconsideration.
Conclusions:
- Cumulated summed differences (cusums) are effective tools for detecting changes in chronic daily headache (CDH).
- Cusums can be applied to enhance both clinical trial designs and stepped-care treatment algorithms for CDH management.